Skip to main content
CLPT logo

ClearPoint Neuro, Inc.

CLPTNASDAQHealthcareMedical Devices

$9.04Today:- (-)1Y −63.40%

As of Oct 26, 2026 close

Market cap
$272.71M
P/E (TTM)
-
Forward P/E
-
Dividend yield
-
52-week range
$8.27$27.27
Volume (live)
-
Avg. volume (3M)
700.55K

ClearPoint Neuro (CLPT) Balance Sheet

As of Dec 31, 2025 (end of fiscal 2025), ClearPoint Neuro reported total assets of $97.75M and total liabilities of $69.73M. Shareholders' equity was $28.02M, up 10.4% from $25.39M a year earlier. Total debt stood at $49.77M against $45.92M in cash and short-term investments, a net debt position of $3.85M. That puts debt-to-equity at 1.78, compared with 0.14 a year earlier.

ClearPoint Neuro Balance Sheet Analysis

Values in millions USD

Scroll to see more
Balance sheet showing assets, liabilities, and shareholders' equity for ClearPoint Neuro, Inc. (CLPT) - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Current Assets
Cash and Cash Equivalents45.9220.1023.1427.6254.1120.105.703.109.29
Short-Term Investments0.000.000.009.870.000.000.000.000.00
Cash & Short-Term Investments45.9220.1023.1437.4954.1120.105.703.109.29
Accounts Receivable6.554.713.942.672.341.881.091.230.95
Inventory8.366.867.919.304.943.243.242.112.31
Other Current Assets2.771.681.181.720.510.240.360.210.19
Total Current Assets63.6033.3636.1751.1861.8925.4610.386.6512.75
Non-Current Assets
Property, Plant & Equipment (Net)11.055.094.952.702.783.060.820.380.27
Goodwill7.470.000.000.000.000.000.000.000.00
Intangible Assets13.920.481.041.030.270.350.000.000.00
Other Non-Current Assets1.700.250.500.580.910.650.720.820.88
Total Non-Current Assets34.155.836.494.313.694.061.541.201.15
Total Assets97.7539.1942.6655.4965.5829.5211.937.8613.90
Current Liabilities
Accounts Payable1.261.340.390.270.430.300.970.500.76
Short-Term Debt0.690.560.420.560.510.390.110.002.00
Accrued Liabilities7.151.451.052.073.141.94---
Deferred Revenue1.672.122.611.070.680.561.020.350.26
Other Current Liabilities7.156.344.004.893.141.941.741.511.38
Total Current Liabilities10.7710.357.436.794.753.203.832.014.40
Non-Current Liabilities
Long-Term Debt49.083.0113.529.899.8423.732.353.482.92
Deferred Tax Liabilities0.350.000.000.000.000.000.000.000.00
Other Non-Current Liabilities0.940.000.000.000.260.000.961.000.75
Total Non-Current Liabilities58.473.4514.0611.8212.0423.943.514.343.67
Total Liabilities69.7313.8021.4918.6016.7927.147.346.358.07
Stockholders' Equity
Common Stock0.290.280.250.250.240.170.150.110.11
Retained Earnings-216.91-191.37-172.46-150.37-133.93-119.52-112.74-107.20-101.04
Accumulated Other Comprehensive Income5.640.000.000.000.000.000.00-1.72-1.67
Additional Paid-in Capital239.00216.48193.38187.01182.48121.73117.17108.60106.76
Shares Outstanding29.3727.6224.6524.5823.67----
Total Stockholders' Equity28.0225.3921.1736.8948.792.384.591.515.83
Total Liabilities & Equity97.7539.1942.6655.4965.5829.5211.937.8613.90

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About ClearPoint Neuro Balance Sheet

How much debt does ClearPoint Neuro have?

ClearPoint Neuro had total debt of $49.77M as of Dec 31, 2025, against $45.92M in cash and short-term investments. Its debt-to-equity ratio was 1.78. Total debt was $3.57M a year earlier.

What are ClearPoint Neuro's total assets?

ClearPoint Neuro reported total assets of $97.75M as of Dec 31, 2025, up 149.4% from $39.19M a year earlier. Total liabilities were $69.73M.

What is ClearPoint Neuro's shareholders' equity?

ClearPoint Neuro's shareholders' equity was $28.02M as of Dec 31, 2025, or about $0.95 of book value per share.

What is the debt-to-equity ratio?

The debt-to-equity ratio divides a company's total debt by its shareholders' equity. It shows how much of the business is financed with borrowed money; normal levels vary widely by industry. Full definition